Monday, April 1, 2019

Four patients receive an experimental treatment against creutzfeldt-Jakob disease in UK

28 Jan 2019
A fourth patient of University College London Hospitals NHS Foundation Trust (UCLH) is to be given a pioneering treatment for Creutzfeldt-Jakob disease (CJD).
 
The Court of Protection today ruled that it was lawful and in the patient’s best interests to receive the unlicensed antibody called PRN100. The patient’s family fully supported UCLH’s application to the court.  
In 2018, we began treating three patients with the PRN100 drug which was developed by researchers at the Medical Research Council (MRC) Prion Unit at University College London (UCL).
The third patient to receive the antibody treatment, who had a very aggressive form of the disease, has sadly died as a result of their condition.
UCLH’s chief executive Professor Marcel Levi said: “On behalf of UCLH, I would like to offer my deepest condolences to the patient’s family and loved ones. They are in our thoughts at this difficult time.”
The first and second patients to receive the drug have not experienced any side effects to date.
Professor John Collinge, director of the MRC Prion Unit at UCL, said: “All of these patients were at different stages of their disease when they began to receive the antibody. It is too early to determine if, or to what extent, the treatment has had an impact on their condition.”



***Update on PRN100: an anti-prion protein monoclonal antibody developed by the MRC Prion Unit for treatment of human prion diseases including Creutzfeldt-Jakob disease (CJD)***
University College London Hospitals NHS Foundation Trust (UCLH) will be treating a patient with the antibody after the Court of Protection confirmed on 8 th October 2018 that it is lawful and in the patient's best interests to receive the treatment.  A statement and Q&A giving more details are available on the UCLH website at http://www.uclh.nhs.uk/News/Pages/PrionCJD.aspx


THURSDAY, MARCH 14, 2019 

USDA APHIS CDC FDA BSE TSE PRION UPDATE 2019



TUESDAY, MARCH 26, 2019 

USDA ARS 2018 USAHA RESOLUTIONS TWO PRONGED APPROACH NEEDED FOR ADVANCING CATTLE TRACEABILITY



THURSDAY, MARCH 14, 2019 

USDA APHIS CDC Cervids: Chronic Wasting Disease Specifics Updated 2019



SATURDAY, MARCH 16, 2019 

Chronic Wasting Disease CWD TSE Prion United States of America Update March 16, 2019



FRIDAY, MARCH 15, 2019 

Saskatchewan Chronic Wasting Disease TSE Prion 349 Cases Positive for 2018



TUESDAY, MARCH 26, 2019 

USDA ARS 2018 USAHA RESOLUTIONS Investigation of the Role of the Prion Protein Gene in CWD Resistance and Transmission of Disease



FRIDAY, MARCH 29, 2019 

First Detection of Chronic Wasting Disease in a Wild Red Deer (Cervus elaphus) in Europe



FRIDAY, MARCH 15, 2019 

USDA APHIS SCRAPIE TSE PRION Sheep and Goat Health Update 2019



TUESDAY, MARCH 26, 2019 

Joint Statement from President Donald J. Trump USA and President Jair Bolsonaro Brazil FOREIGN POLICY BSE TSE Prion aka mad cow disease



THURSDAY, MARCH 28, 2019 

FSA Abattoir fined more than £265,000 for failure to follow public health regulations SRM'S TSE PRION



Mexico ???


terry

No comments: